Refine by
Chemotherapy Treatment Articles & Analysis
6 articles found
Leukemia, a malignant disorder of the blood and bone marrow, poses significant challenges to both patients and healthcare providers. Traditional treatments, including chemotherapy and radiation, while effective for some, often come with severe side effects and varied success rates. ...
Background and objective High grade serous carcinoma (HGSC) of the ovary is a complex and deadly disease. Although frontline treatment of chemotherapy and surgery is often effective, with nearly all patients experiencing remission, over 80% of patients will experience disease recurrence in the first two years and ultimately die of the disease. ...
Currently, multiple antibody drugs have been approved for the treatment of various diseases, such as cancer, autoimmune diseases, and infectious diseases. Antibody drugs have become an important means of treating some diseases, while also providing clinicians with more treatment options. For example, monoclonal or polyclonal antibodies have been used in some ...
Abstract We developed a series of models to predict the likelihood of recurrence and the response to chemotherapy for the personalized treatment of stage I and II colorectal cancer patients. ...
Only beneficiaries with specific cancer diagnoses and who are receiving systemic chemotherapy treatment (excluding exclusively hormonal therapies) are eligible for EOM, these include: breast cancer, lung cancer, lymphoma, multiple myeloma, small intestine/colorectal, prostate cancer, and chronic leukemia. ...
With that information in hand, it is possible to investigate the differences between normal physiology and disease states to determine what goes wrong with stem cells during disease processes and ultimately to evaluate how different treatments for disease can impact stem cells. For instance, radiation or chemotherapy treatments for cancer can ...